Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotech company translating scientific advances into transformative therapies for patients with devastating rare diseases. Focus on rare benign hematology, immuno-inflammation, thrombocytopenia, auto-immune disease, iron regulation, ineffective erythropoiesis